| pubmed-article:20682682 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20682682 | lifeskim:mentions | umls-concept:C0927232 | lld:lifeskim |
| pubmed-article:20682682 | lifeskim:mentions | umls-concept:C0205054 | lld:lifeskim |
| pubmed-article:20682682 | lifeskim:mentions | umls-concept:C0040615 | lld:lifeskim |
| pubmed-article:20682682 | lifeskim:mentions | umls-concept:C0021655 | lld:lifeskim |
| pubmed-article:20682682 | lifeskim:mentions | umls-concept:C0011209 | lld:lifeskim |
| pubmed-article:20682682 | lifeskim:mentions | umls-concept:C0171023 | lld:lifeskim |
| pubmed-article:20682682 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:20682682 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:20682682 | pubmed:dateCreated | 2010-9-29 | lld:pubmed |
| pubmed-article:20682682 | pubmed:abstractText | Olanzapine (OLZ) is an atypical antipsychotic whose clinical efficacy is hampered by side effects including weight gain and diabetes. Recent evidence shows that OLZ alters insulin sensitivity independent of changes in body weight and composition. The present study addresses whether OLZ-induced insulin resistance is driven by its central actions. | lld:pubmed |
| pubmed-article:20682682 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20682682 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20682682 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:20682682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20682682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20682682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20682682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20682682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20682682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20682682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20682682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20682682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20682682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20682682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20682682 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20682682 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:20682682 | pubmed:issn | 1939-327X | lld:pubmed |
| pubmed-article:20682682 | pubmed:author | pubmed-author:ObiciSilvanaS | lld:pubmed |
| pubmed-article:20682682 | pubmed:author | pubmed-author:HaasMichaelM | lld:pubmed |
| pubmed-article:20682682 | pubmed:author | pubmed-author:MartinsPaulo... | lld:pubmed |
| pubmed-article:20682682 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20682682 | pubmed:volume | 59 | lld:pubmed |
| pubmed-article:20682682 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20682682 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20682682 | pubmed:pagination | 2418-25 | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:meshHeading | pubmed-meshheading:20682682... | lld:pubmed |
| pubmed-article:20682682 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20682682 | pubmed:articleTitle | Central nervous system delivery of the antipsychotic olanzapine induces hepatic insulin resistance. | lld:pubmed |
| pubmed-article:20682682 | pubmed:affiliation | Obesity Research Center, University of Cincinnati, Cincinnati, Ohio, USA. | lld:pubmed |
| pubmed-article:20682682 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20682682 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20682682 | lld:pubmed |
